Last reviewed · How we verify
high-dose metformin
At a glance
| Generic name | high-dose metformin |
|---|---|
| Sponsor | Jing-yuan Fang, MD, Ph. D |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function (PHASE2)
- A Study to Evaluate VH4524184 Tablet Absorption, Effects of Food, and Interactions With Other Drugs in Healthy Adults (PHASE1)
- Safety and Feasibility of Metformin for Sepsis Induced AKI (PHASE2)
- A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain Injury (PHASE1)
- Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes (PHASE2)
- A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus and High Body Mass Index (BMI) (PHASE4)
- A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging (PHASE2)
- Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |